POU5F1 and pancreatic ductal adenocarcinoma: In pancreatic ductal adenocarcinoma, GZ17-6.02 can decrease the occupancy of master transcription factor Oct4 in SE regions, reduce the activity of SEs, and thereby inhibit the growth of pancreatic ductal adenocarcinoma cells (Ghosh et al., 2019).